Australia - English - Department of Health (Therapeutic Goods Administration)

seqirus pty ltd - influenza virus haemagglutinin, quantity: 30 microgram/ml - injection, suspension - excipient ingredients: sodium chloride; potassium chloride; monobasic potassium phosphate; dibasic sodium phosphate dihydrate; magnesium chloride hexahydrate; calcium chloride dihydrate; squalene; polysorbate 80; sorbitan trioleate; sodium citrate dihydrate; citric acid monohydrate; water for injections - active immunisation against influenza in the elderly (65 years of age and older), especially for those with an increased risk of associated complications (i.e. patients affected by underlying chronic diseases including diabetes, cardiovascular and respiratory diseases).

Australia - English - Department of Health (Therapeutic Goods Administration)

seqirus pty ltd - ciclosporin, quantity: 1 mg/ml - eye drops, emulsion - excipient ingredients: medium chain triglycerides; cetalkonium chloride; glycerol; tyloxapol; poloxamer; sodium hydroxide; water for injections - treatment of severe keratitis in adult patients with dry eye disease which has not improved despite treatment with tear substitutes.

Australia - English - Department of Health (Therapeutic Goods Administration)

seqirus pty ltd - coxiella burnetii, quantity: 5 microgram/ml - injection - excipient ingredients: sodium chloride; monobasic sodium phosphate dihydrate; thiomersal; water for injections; dibasic sodium phosphate dodecahydrate - q-vax is indicated for the immunisation of susceptible adults at identifiable risk of infection with q fever. abattoir workers (and those closely associated with the meat industry), farmers, veterinarians, stockyard workers, shearers, animal transporters and many others exposed to cattle, sheep or goats or their products should be considered for vaccination. note: q fever has also occurred among persons culling and processing kangaroos and laboratory personnel handling potentially infected veterinary specimens, or visiting abattoirs, are at risk.

Australia - English - Department of Health (Therapeutic Goods Administration)

seqirus pty ltd - coxiella burnetii, quantity: 50 microgram/ml - injection - excipient ingredients: monobasic sodium phosphate dihydrate; thiomersal; dibasic sodium phosphate dodecahydrate; water for injections; sodium chloride - q-vax is indicated for the immunisation of susceptible adults at identifiable risk of infection with q fever. abattoir workers (and those closely associated with the meat industry), farmers, veterinarians, stockyard workers, shearers, animal transporters and many others exposed to cattle, sheep or goats or their products should be considered for vaccination. note: q fever has also occurred among persons culling and processing kangaroos and laboratory personnel handling potentially infected veterinary specimens, or visiting abattoirs, are at risk.

Australia - English - Department of Health (Therapeutic Goods Administration)

seqirus pty ltd - sea snake antivenom, quantity: 1000 u - injection, concentrated - excipient ingredients: phenol; sodium chloride; water for injections - for the treatment of patients who exhibit manifestations of systemic envenoming following a bite by a sea snake.

Australia - English - Department of Health (Therapeutic Goods Administration)

seqirus pty ltd - death adder antivenom, quantity: 6000 u; brown snake antivenom, quantity: 1000 u; black snake antivenom, quantity: 18000 u; tiger snake antivenom, quantity: 3000 u; taipan antivenom, quantity: 12000 u - injection, concentrated - excipient ingredients: phenol; sodium chloride; water for injections - for the treatment in papua new guinea and in all states except victoria and tasmania who exhibit manifestations of systemic envenoming and the snake has not been identified. in tasmania, tiger snake antivenom should be used rather than polyvalent whilst in victoria a combination of tiger snake antivenom and brown snake antivenom is the preferred treatment.

Australia - English - Department of Health (Therapeutic Goods Administration)

seqirus pty ltd - taipan antivenom, quantity: 12000 u - injection, concentrated - excipient ingredients: sodium chloride; phenol; water for injections - for the treatment of patients who exhibit manifestations of systemic envenoming following a bite by a taipan.

Australia - English - Department of Health (Therapeutic Goods Administration)

seqirus pty ltd - brown snake antivenom, quantity: 1000 u - injection, concentrated - excipient ingredients: phenol; sodium chloride; water for injections - for the treatment of patients who exhibit manifestations of systemic envenoming following a bite by a snake of the genus pseudonaja. this genus includes the eastern brown snake, the dugite and the gwardar (western brown snake).

Australia - English - Department of Health (Therapeutic Goods Administration)

seqirus pty ltd - death adder antivenom, quantity: 6000 u - injection, concentrated - excipient ingredients: sodium chloride; phenol; water for injections - for the treatment of patients who exhibit manifestations of systemic envenoming following a bite by a death adder.

Australia - English - Department of Health (Therapeutic Goods Administration)

seqirus pty ltd - tiger snake antivenom, quantity: 3000 u - injection, concentrated - excipient ingredients: sodium chloride; phenol; water for injections - for the treatment of patients who exhibit manifestations of systemic envenoming following a bite of a tiger, copperhead or black snake.